Status: Recruiting
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
The study is designed to validate efficacy and long term safety of PP405.
Participants needed: 600
Trial details
Phase: Phase 2, Phase 3Age: 18-55Biological sex: MaleType: InterventionalSponsor: Pelage Pharmaceuticals, Inc.Updated: Oct 7, 2026Locations: 22
Eligibility criteria
Males (assigned at birth) aged 18 to 55 years, inclusive at time of consent. [+4]
Concomitant diagnosis of non-AGA forms of alopecia. [+4]